Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV411 (Ibudilast) for Heroin Withdrawal and Oxycodone Analgesia
NCT00723177Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Oct 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibudilast in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Oct 2008; status: completed.
02
Drugs
ibudilast
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00723177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723177.